DHR

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Danaher Corp.

Danaher Corporation is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets. With more than 20 operating companies, Danaher's globally diverse team of approximately 69,000 associates is united by a common culture and operating system, the Danaher Business System, and its Shared Purpose, Helping Realize Life's Potential.
CEO
H. Lawrence Culp
Employees
2020
Headquarters

2200 Pennsylvania Ave NW Ste 800W
Washington, Washington Dc 20037-1731
Phone: 12028280850
www.danaher.com

News

Top 5 2nd Quarter Trades of CHILTON INVESTMENT CO INC.
Aug 17, 2022 01:00am

Related Stocks: BRK.B , EQH , MCO , DPZ , DHR ,


Source:GuruFocus
RMB Capital Management, LLC Buys 4, Sells 1 in 2nd Quarter
Aug 17, 2022 01:00am

Related Stocks: SCHD , MSFT , AMZN , AZPN , DHR ,


Source:GuruFocus
Top 5 2nd Quarter Trades of STATE STREET CORP
Aug 16, 2022 23:00pm

Related Stocks: DHR , AAPL , BSX , BRK.B , MSFT ,


Source:GuruFocus
Top 5 2nd Quarter Trades of OMERS ADMINISTRATION Corp
Aug 13, 2022 01:00am

Related Stocks: INTU , DHR , ADBE , SHW , XLE ,


Source:GuruFocus
Lab Automation Market Huge Growth in Future Scope 2022-2028 | Tecan Group Ltd., PerkinElmer Inc., Danaher Corporation, Thermo Fisher Scientific
Aug 12, 2022 10:40am

The global "Lab Automation Market" report aims to provide a detailed analysis of the factors that influence the global business adoption and segmentation outlook. The detailed information and overview of the global Lab Automation market report highlight the latest development


Source:OpenPR
These 21 companies are making their debut on the Fortune Global 500 list in 2022
Aug 06, 2022 10:00am

CarMax, BYD, and Danaher are among the first-timers on the list of the world’s largest companies.


Source:Fortune
Top 5 2nd Quarter Trades of Wills Financial Group, Inc.
Aug 05, 2022 23:00pm

Related Stocks: BX , MDT , SBUX , DHR , GOOGL ,


Source:GuruFocus
Filters Market is projected to expand at a steady CAGR over the forecast by 2031 | Ahlstrom-Munksjö, ALFA LAVAL, Danaher (Pall Corporation)
Aug 04, 2022 07:44am

New York, 2022-Jul-14 — /EPR Network/ — Global Filters Market report from Global Insight Services is the single authoritative source of intelligence on Filters Market. The report [read full press release…]


Source:Express Press Release Distribution
Cannabis Testing Market Pegged for Robust Expansion by 2031 | Type, Application, Scope & Key Companies | Agilent Technologies Inc., Danaher Corporation, Merck KGAA
Aug 03, 2022 09:36am

New York, 2022-Jul-14 — /EPR Network/ — Global Cannabis Testing Market report from Global Insight Services is the single authoritative source of intelligence on Cannabis Testing Market. [read full press release…]


Source:Express Press Release Distribution
Danaher Corporation – Consensus Indicates Potential 11.7% Upside
Aug 02, 2022 12:03pm

Danaher Corporation with ticker code (DHR) have now 18 analysts in total covering the stock. The consensus rating is ''Buy''. The target price ranges between 363.4 and 275 with a mean TP of 325.52. Given that the stocks previous close was at 291.47 this is indicating there is a potential upside of 11.7%. The 50 day MA is 259.16 and the 200 day MA is 281.96. The market capitalisation for the company is $209,431m. Company Website: https://www.danaher.com [stock_market_widget type="chart" template="basic" color="green" assets="DHR" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $233,898m based on the market concensus. Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.


Source:DirectorsTalk
Here''s How Much You Would Have Made Owning Danaher Stock In The Last 5 Years
Jul 29, 2022 15:31pm

Danaher (NYSE: DHR ) has outperformed the market over the past 5 years by 18.67% on an annualized basis producing an average annual return of 29.35%. Currently, Danaher has a market capitalization of $212.88 billion. Buying $100 In DHR: If an … Full story available on Benzinga.com


Source:Benzinga
Top 5 2nd Quarter Trades of FOREFRONT WEALTH MANAGEMENT INC.
Jul 28, 2022 19:00pm

Related Stocks: DHR , FALN , BBRE , ABBV , QCOM ,


Source:GuruFocus
Danaher And 2 Other Stocks Insiders Are Selling
Jul 27, 2022 14:02pm

US stocks traded higher on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision. Below is a look at a few recent notable insider sales. For more, check out Benzinga''s insider transactions platform. Danaher The Trade: Danaher Corporation (NYSE: DHR ) Executive Vice President Joakim Weidemanis sold a total … Full story available on Benzinga.com


Source:Benzinga
Top 5 2nd Quarter Trades of VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P.
Jul 23, 2022 03:00am

Related Stocks: MKC , DG , DHR , GOOGL , CHD ,


Source:GuruFocus
Danaher PT Lowered to $299 at CFRA
Jul 22, 2022 17:22pm

https://www.investing.com/news/pro/danaher-pt-lowered-to-299-at-cfra-432SI-2852183


Source:Investing.com
Top 5 2nd Quarter Trades of Trust Investment Advisors
Jul 22, 2022 15:00pm

Related Stocks: DVN , AAPL , MPW , DHR , PYPL ,


Source:GuruFocus
Danaher Posts Upbeat Q2 Results; Street Says Buy
Jul 22, 2022 14:42pm

Shares of Danaher Corporation (DHR) jumped over 9% on July 21 after the company delivered better-than-expected second-quarter results. Danaher Corp is a globally diversified conglomerate that engages in the manufacturing, designing, and marketing of medical, industrial, and commercial products and services. A Snapshot of Danaher''s Q2 Results The company reported stellar quarterly earnings of $2.76 per share, higher than analysts’ estimates of $2.35 per share. Danaher had posted earnings of $2.46 per share in the same quarter last year. Meanwhile, revenue climbed 7.5% year-over-year to $7.8 billion and surpassed the Street’s estimate of $7.32 billion. The revenue growth is attributed to adjusted core revenue growth of 9.5%.


Source:TipRanks
Danaher Proves It''s A Total Return Star (NYSE:DHR)
Jul 22, 2022 14:34pm

Danaher executes at a very high level in a tough economic environment. See why I made the decision to add low-yielding DHR stock to my dividend growth portfolio.


Source:Seeking Alpha
Danaher Earnings Perspective: Return On Invested Capital
Jul 22, 2022 13:51pm

Pulled from Benzinga Pro data, Danaher (NYSE: DHR ) showed a loss in earnings since Q1, totaling $1.68 billion. Sales, on the other hand, increased by 0.82% to $7.75 billion during Q2. Danaher reached earnings of $1.73 billion and sales of $7.69 billion in Q1. What Is Return On Invested Capital? Earnings data without context is not clear and can difficult to base trading decisions on. Return on Invested Capital (ROIC) helps to filter signal from noise by measuring yearly pre-tax profit relative to invested capital by a business. Generally, a higher ROIC suggests successful growth of a company and is a sign of higher earnings … Full story available on Benzinga.com


Source:Benzinga
Pharmaceutical Lab Equipment Market to See Booming Growth 2022-2028 | GE Healthcare, Agilent Technologies, Waters, Danaher, Thermo Fisher Scientific
Jul 22, 2022 11:06am

The global "Pharmaceutical Lab Equipment Market" report aims to provide a detailed analysis of the factors that influence the global business adoption and segmentation outlook. The detailed information and overview of the global Pharmaceutical Lab Equipment market report highlight the


Source:OpenPR
Danaher PT Raised to $317 at RBC Capital
Jul 22, 2022 10:34am

https://www.investing.com/news/pro/danaher-pt-raised-to-317-at-rbc-capital-432SI-2851697


Source:Investing.com
Danaher earnings boost other diagnostics, life sciences support companies (NYSE:DHR)
Jul 21, 2022 17:44pm

Diagnostics companies and others that support the life sciences industry are higher in Thursday afternoon trading following Danaher''s (DHR) Q2 2022 top and bottom lines beats.


Source:Seeking Alpha
Danaher maneuvers through tangled supply chain to make great quarterly earnings
Jul 21, 2022 17:35pm

It was a great quarter for Danaher as those strong headline results were met with operating margin expansion.


Source:CNBC
Hot Stocks: PM, NOK, DHR rally on earnings news; AAL drops on capacity worries
Jul 21, 2022 17:20pm

PM, NOK and DHIR rose on earnings news. AAL dropped on concerns about its capacity.


Source:Seeking Alpha
Danaher PT Raised to $300 at Evercore ISI
Jul 21, 2022 16:42pm

https://www.investing.com/news/pro/danaher-pt-raised-to-300-at-evercore-isi-432SI-2850968


Source:Investing.com
Stocks making the biggest moves midday: Danaher, Tesla, AT&T and more
Jul 21, 2022 16:32pm

These are the stocks posting the largest moves in midday trading.


Source:CNBC
Danaher Corporation 2022 Q2 - Results - Earnings Call Presentation
Jul 21, 2022 12:02pm

The following slide deck was published by Danaher Corporation in conjunction with their 2022 Q2 earnings call.


Source:Seeking Alpha
Danaher Easily Beats Q2 Street View With Growth From Base Business; FY22 Outlook Unchanged
Jul 21, 2022 11:28am

Danaher Corp (NYSE: DHR ) has logged Q2 FY22 adjusted EPS of $2.76 , up 12% Y/Y, surpassing the estimate of $2.35. Sales increased 7.5% to $7.75 billion, with 9.5% non-GAAP core and 8.0% non-GAAP base business core revenue growth, beating the $7.32 billion estimate. Operating cash flow reached $2 billion. Non-GAAP free cash … Full story available on Benzinga.com


Source:Benzinga
Danaher: Q2 Earnings Insights
Jul 21, 2022 11:17am

Danaher (NYSE: DHR ) reported its Q2 earnings results on Thursday, July 21, 2022 at 06:00 AM. Here''s what investors need to know about the announcement. Earnings Danaher beat estimated earnings by 17.45%, reporting an EPS of $2.76 versus an … Full story available on Benzinga.com


Source:Benzinga
Danaher Q2 sales see impact on COVID products but still soar beating estimates
Jul 21, 2022 11:06am

Danaher (DHR) Q2 total sales grew to $7.75B but COVID-19 related testing products showed a decline.The company saw a -1.5% Y/Y negative impact of COVID-19 related testing, compared to…


Source:Seeking Alpha
Danaher Corp. Q2 Profit Decreases, but beats estimates
Jul 21, 2022 10:28am

WASHINGTON (dpa-AFX) - Danaher Corp. (DHR) revealed a profit for second quarter that decreased from last year but beat the Street estimates.The company''s earnings totaled $1.66 billion, or $2.25 p…


Source:Finanz Nachrichten
Top 5 2nd Quarter Trades of EASTERN BANK
Jul 20, 2022 19:00pm

Related Stocks: LQD , SRLN , HIG , ICE , DHR ,


Source:GuruFocus
Danaher Q2 2022 Earnings Preview (NYSE:DHR)
Jul 20, 2022 17:33pm

Danaher (DHR) is scheduled to announce Q2 earnings results on Thursday, July 21st, before market open.The consensus EPS Estimate is $2.34 (-4.9% Y/Y) and the consensus Revenue Estimate…


Source:Seeking Alpha
Earnings Outlook For Danaher
Jul 20, 2022 15:09pm

Danaher (NYSE: DHR ) is set to give its latest quarterly earnings report on Thursday, 2022-07-21. Here''s what investors need to know before the announcement. Analysts estimate that Danaher will report an earnings per share (EPS) of $2.35. Danaher bulls will hope to hear the company to announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the … Full story available on Benzinga.com


Source:Benzinga
Danaher Corporation (NYSE: DHR) Stock Seems Like A Good Option
Jul 15, 2022 18:00pm

Danaher Corporation (NYSE:DHR) shares, rose in value on Friday, July 15, with the stock price up by 2.66% to the previous day’s close as strong demand from buyers drove the stock to $254.65. Actively observing the price movement in the recent trading, the stock is buoying the session at $248.06, falling within a range of … Danaher Corporation (NYSE: DHR) Stock Seems Like A Good Option Read More »


Source:Stocks Register
Looking Into Danaher''s Recent Short Interest
Jul 15, 2022 16:11pm

Danaher''s (NYSE: DHR ) short percent of float has risen 20.63% since its last report. The company recently reported that it has 4.83 million shares sold short , which is 0.76% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.9 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price … Full story available on Benzinga.com


Source:Benzinga
Danaher Corporation (NYSE: DHR) Shares Have Been Down About -23.68% Year-To-Date Since The Beginning Of 2022
Jul 14, 2022 17:00pm

During the recent session, Danaher Corporation (NYSE:DHR)’s traded shares were 0.84 million, with the beta value of the company hitting 0.83. At the last check today, the stock’s price was $243.50, reflecting an intraday loss of -3.02% or -$7.59. The 52-week high for the DHR share is $333.96, that puts it down -37.15 from that … Danaher Corporation (NYSE: DHR) Shares Have Been Down About -23.68% Year-To-Date Since The Beginning Of 2022 Read More »


Source:Marketing Sentinel
$32.9 Billion Worldwide Synthetic Biology Industry to 2027 - Featuring Amyris, Codexis and Danaher Among Others - ResearchAndMarkets.com
Jul 13, 2022 14:43pm

DUBLIN--(BUSINESS WIRE)--The "Synthetic Biology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com''s offering. The global synthetic biology market reached a value of US$ 11.17 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 32.93 Billion by 2027, exhibiting a CAGR of 19.74% during 2021-2027. Companies Mentioned Agilent Technologies Inc. Amyris Inc. Codexis Inc. Danahe


Source:Business Wire
Here''s How Much $100 Invested In Danaher 10 Years Ago Would Be Worth Today
Jul 12, 2022 21:31pm

Danaher (NYSE: DHR ) has outperformed the market over the past 10 years by 9.88% on an annualized basis producing an average annual return of 20.69%. Currently, Danaher has a market capitalization of $183.99 billion. Buying $100 In DHR: If an … Full story available on Benzinga.com


Source:Benzinga
Genomics Market Top Players Analysis | Beijing Genomics Institute, Danaher Corporation, Oxford Nanopore Technologies, GE Healthcare and Among Others
Jul 08, 2022 03:28am

Pune, July 07, 2022 (GLOBE NEWSWIRE) -- Genomics Market by Vendor Assessment, Technology Assessment, Partner & Customer Ecosystem, type/solution, service, organization size, end-use verticals, and Region – Global Genomics Market Forecast to 2030, published by Market Data Centre, The Genomics Market is projected to grow at a solid pace during the forecast period. The presence of key players in the ecosystem has led to a compsetitive and diverse market. The advancement of digital transformation initiatives across multiple industries is expected to drive the worldwide Genomics Market during the study period. This COVID-19 analysis of the report includes COVID-19 IMPACT on the production and, demand, supply chain. This report provides a detailed historical analysis of the global Genomics Market from 2017-to 2021 and provides extensive market forecasts from 2022-to 2030 by region/country and subsectors. The report covers the revenue, sales volume, price, historical growth, and future perspectives in the Genomics Market.


Source:Benzinga
Danaher Corporation – Consensus Indicates Potential 29.5% Upside
Jul 05, 2022 10:19am

Danaher Corporation found using ticker (DHR) now have 18 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 363.4 and 265 with the average target price sitting at 328.41. Given that the stocks previous close was at 253.52 this would indicate that there is a potential upside of 29.5%. The day 50 moving average is 252.96 and the 200 day moving average is 286.31. The company has a market capitalisation of $187,622m. Find out more information at: https://www.danaher.com [stock_market_widget type="chart" template="basic" color="green" assets="DHR" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $243,046m based on the market concensus. Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.


Source:DirectorsTalk
Danaher Stock: A Much Needed Pullback (NYSE:DHR)
Jul 03, 2022 09:42am

Danaher (DHR) is a Dividend Challenger with 8 consecutive years of dividend growth. DHR shares currently yield 0.39%. See why I am not purchasing DHR stock now.


Source:Seeking Alpha
How Is The Market Feeling About Danaher?
Jun 29, 2022 18:15pm

Danaher''s (NYSE: DHR ) short percent of float has fallen 7.35% since its last report. The company recently reported that it has 3.99 million shares sold short , which is 0.63% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.5 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price … Full story available on Benzinga.com


Source:Benzinga
The Worldwide Carrier Screening Industry is Expected to Reach $3.64 Billion by 2030
Jun 29, 2022 09:53am

Dublin, June 29, 2022 (GLOBE NEWSWIRE) -- The "Carrier Screening Market Share, Size, Trends, Industry Analysis Report, By Type; By Medical Condition; By Technology; By End-User; By Regions; Segment Forecast, 2022 - 2030" report has been added to ResearchAndMarkets.com''s offering. The global carrier screening market size is expected to reach USD 3.64 billion by 2030, according to a new study. The report gives a detailed insight into current market dynamics and provides analysis on future market growth. The well-established healthcare infrastructure and the rise in innovative product introductions are driving the expansion of the industry. Many countries concentrate their efforts on developing enhanced medical infrastructure that includes enhanced treatment techniques. Furthermore, developed-country nations have modern healthcare infrastructure integrated with various transmission methods, pushing the rise and need for these techniques throughout such countries. Many people wish to discover if their genetic or inherited disorders might be transmitted to their offerings.


Source:GlobeNewswire
Here''s How Much $100 Invested In Danaher 20 Years Ago Would Be Worth Today
Jun 28, 2022 14:21pm

Danaher (NYSE: DHR ) has outperformed the market over the past 20 years by 7.67% on an annualized basis producing an average annual return of 14.78%. Currently, Danaher has a market capitalization of $186.88 billion. Buying $100 In DHR: If an … Full story available on Benzinga.com


Source:Benzinga
Danaher Schedules Second Quarter 2022 Earnings Conference Call
Jun 21, 2022 20:30pm

WASHINGTON, June 21, 2022 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2022 on Thursday, July 21, 2022 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying…


Source:PR Newswire
Danaher Corporation – Consensus Indicates Potential 36.4% Upside
Jun 21, 2022 09:38am

Danaher Corporation found using ticker (DHR) have now 18 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 363.4 and 265 calculating the average target price we see 328.41. Given that the stocks previous close was at 240.85 this indicates there is a potential upside of 36.4%. The day 50 moving average is 258.67 while the 200 day moving average is 289.71. The market capitalisation for the company is $173,481m. You can visit the company''s website by visiting: https://www.danaher.com [stock_market_widget type="chart" template="basic" color="green" assets="DHR" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $236,549m based on the market concensus. Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions.


Source:DirectorsTalk